NEW YORK, Nov. 28 /PRNewswire/ -- The world's largest contract research organization, Quintiles Transnational Corp., has signed a strategic agreement to make IntraLinks(R) On-Demand Workspaces(TM) available to its worldwide pharmaceutical customer base to increase the speed and efficiency of managing the critical start-up phase for clinical trials. IntraLinks, through its On- Demand Workspaces, enables users to upload, monitor and exchange critical documents with multiple parties around the world when email, fax and overnight shipping are not secure or efficient enough. Quintiles has helped develop or commercialize each of the top 30 best-selling pharmaceuticals and nine of the top 10 biotech medications.
The start-up phase of a clinical trial begins with the distribution of numerous regulatory documents to an ever-increasing number of clinical investigative sites located throughout the world. The distribution and collection of documents by sponsors or contract research organizations (CRO) such as Quintiles, are regulated by the FDA and other world regulatory bodies. IntraLinks enables investigative sites, CROs and sponsors to share information online through a secure, compliant repository, and to reduce the time in which to facilitate the first patient visit and help streamline the flow of documentation throughout the trial.
"As a market leader, Quintiles' customers count on us to stay on the leading edge of technology and provide solutions that reduce the drug development timeline, while still meeting strict regulatory requirements. The sheer volume of documentation necessary to begin a clinical trial is cumbersome at best. We are partnering with IntraLinks to provide our customers with a best-of-class document distribution and management solution," said Jamie Macdonald, Senior Vice President, Quintiles' Head of North America Clinical Operations.
"We are delighted that Quintiles has chosen to partner with IntraLinks to realize substantial time savings and simplify the growing logistical complexity of clinical trials. By utilizing IntraLinks' On-Demand Workspaces, Quintiles is leveraging proven technology that can more efficiently and effectively distribute business-critical documentation and ultimately, decrease the cycle time to commence the trials," said David Espenshade, Vice President for Life Sciences at IntraLinks.
IntraLinks(R) On-Demand Workspaces(TM) connect business communities and accelerate the intelligent flow of information and documents among participants. Through IntraLinks' secure, neutral, online environments, companies are better able to compete globally by accelerating essential business processes, simplifying communication and fostering rapid workflow. IntraLinks is easily accessible anywhere, anytime, using a web browser.
Since 1997, more than 700,000 participants representing over 80,000 organizations worldwide have used IntraLinks On-Demand Workspaces(TM) to communicate and collaborate on thousands of projects and transactions. IntraLinks has been adopted widely in the financial services and pharmaceutical industries, where its clients include AstraZeneca Pharmaceuticals LP, Bank of America, Bear Stearns, Deutsche Bank, FDIC, TD Securities, Thomas Weisel Partners and WestLB, among hundreds of others. Founded in 1996, IntraLinks is headquartered in New York with offices around the world. For more information, visit www.intralinks.com.
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, information, financial partnering and commercialization for the pharmaceutical and biotechnology industries. With more than 19,000 employees and offices in more than 50 countries, it is focused on providing customer- centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at www.quintiles.com.
CONTACT: Shelley Pfaendler of KCSA Worldwide, +1-212-896-1248, or
email@example.com, for IntraLinks
Web site: http://www.intralinks.com/